Form EFFECT Milestone Pharmaceutical
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 22, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Memberships at Crunch Fitness Southington, CT Go On Sale Saturday June 27th
- Integral Molecular Earns Back-to-Back Top Workplace Honors from The Philadelphia Inquirer
- David Mayman Recognized by LA Times as 2026 Aerospace and Defense Visionary
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
